You have 9 free searches left this month | for more free features.

GN

Showing 1 - 25 of 1,495

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Psoriasis Trial in Kayseri (GN037, Placebo)

Active, not recruiting
  • Psoriasis
  • Kayseri, Turkey
    Erciyes University IKUM Center
Jul 26, 2022

Abdominal Aortic Aneurysm Trial in Cleveland (3D Holographic Guidance, Navigation, and Control (3D GN&C))

Not yet recruiting
  • Abdominal Aortic Aneurysm
  • 3D Holographic Guidance, Navigation, and Control (3D GN&C)
  • Cleveland, Ohio
    Cleveland Clinic
Aug 28, 2023

Psoriasis Trial in Turkey (GN037, Clobetasol 17-Propionate Cream, Placebo)

Recruiting
  • Psoriasis
  • Ankara, Turkey
  • +11 more
Jan 23, 2023

QIAstat-Dx® BCID Plus AMR Panels Clinical Performance Study

Not yet recruiting
  • Blood Disease
  • QIAstat-Dx® BCID GN and GPF Plus AMR Panels
  • (no location specified)
Mar 22, 2022

Metabolic Associated Fatty Liver Disease and Biopsy Proved Cases

Recruiting
  • Assessment of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years of Age for MFLD Development
    • Asyut, Egypt
    • +1 more
    Nov 27, 2023

    IVF, Infertility Trial in Mansoura (estradiol plus progesterone 100 mg IM injection, Progesterone IM of 100 mg)

    Completed
    • IVF
    • Infertility
    • estradiol plus progesterone 100 mg IM injection
    • Progesterone IM of 100 mg
    • Mansoura, Dekahlia, Egypt
      Mansoura Integrated fertility center
    Jun 14, 2022

    Tinnitus, Subjective Trial in Urbana (Resound Relief smartphone app)

    Active, not recruiting
    • Tinnitus, Subjective
    • Resound Relief smartphone app
    • Urbana, Illinois
      University of Illinois at Urbana-Champaign
    Sep 27, 2021

    Vertigo, Dizziness Trial in United States (VRT Care)

    Active, not recruiting
    • Vertigo
    • Dizziness
    • VRT Care
    • Peoria, Illinois
    • +4 more
    Aug 11, 2022

    Erectile Dysfunction Trial in Zürich (Genital Nerves Stimulation)

    Not yet recruiting
    • Erectile Dysfunction
    • Genital Nerves Stimulation
    • Zürich, Switzerland
      Possover
    Jan 28, 2022

    MDD, Childhood Trauma Trial in Amsterdam, Woerden, Utrecht (Treatment as usual (TAU) for depression, Trauma-focused therapy

    Recruiting
    • Major Depressive Disorder
    • Childhood Trauma
    • Treatment as usual (TAU) for depression
    • Trauma-focused therapy (TFT)
    • Amsterdam, Noord-Holland, Netherlands
    • +2 more
    Apr 20, 2022

    Membranoproliferative Glomerulonephritis Trial in Rochester (Daratumumab)

    Completed
    • Membranoproliferative Glomerulonephritis
    • Rochester, Minnesota
      Mayo Clinic
    Jun 28, 2021

    Nonalcoholic Steatohepatitis, Type 2 Diabetes Trial (TEV-45478, Placebo)

    Withdrawn
    • Nonalcoholic Steatohepatitis
    • Type 2 Diabetes Mellitus
    • (no location specified)
    Nov 5, 2021

    Hantaan Virus Trial in Silver Spring (Hantaan Vaccine:, Puumala Vaccine, Hantaan/Puumala Vaccine)

    Completed
    • Hantaan Virus
    • Hantaan Vaccine:
    • +2 more
    • Silver Spring, Maryland
      WRAIR Clinical Trials Center
    Feb 10, 2021

    Parkinson Disease Trial in Netherlands, United Kingdom, United States (RO7486967, Placebo)

    Recruiting
    • Parkinson Disease
    • Birmingham, Alabama
    • +12 more
    Jun 21, 2023

    Polycystic Ovary Syndrome, Anovulation Trial (Laparoscopic ovarian drilling, Recombinant FSH (rFSH))

    Not yet recruiting
    • Polycystic Ovary Syndrome
    • Anovulation
    • Laparoscopic ovarian drilling
    • Recombinant FSH (rFSH)
    • (no location specified)
    Oct 12, 2020

    Seasonal Allergic Rhinitis Trial in Ankara (other, behavioral, diagnostic test)

    Unknown status
    • Seasonal Allergic Rhinitis
    • "Total nasal symptom score" (TNSS)
    • +3 more
    • Ankara, Etlik, Turkey
    • +1 more
    Feb 10, 2021

    Chronic Cluster Headache Trial in Worldwide (Eptinezumab)

    Active, not recruiting
    • Chronic Cluster Headache
    • Stamford, Connecticut
    • +30 more
    Jan 18, 2023

    Adverse Drug Reactions Trial in Ankara (Survey)

    Completed
    • Adverse Drug Reactions
    • Survey
    • Ankara, Etlik, Turkey
      Health Sciences University, Gülhane Training and Research Hospit
    Sep 18, 2020

    Gram-negative Bacteremia Trial (Intravenous Antibiotics, Oral Antibiotics)

    Not yet recruiting
    • Gram-negative Bacteremia
    • Intravenous Antibiotics
    • Oral Antibiotics
    • (no location specified)
    Oct 6, 2023

    Healthy Subjects Trial in Groningen (Single ascending doses of FM101, Multiple ascending doses of FM101, Food effects of FM101)

    Completed
    • Healthy Subjects
    • Single ascending doses of FM101
    • +2 more
    • Groningen, Gn, Netherlands
      PRA health Sciences
    Sep 7, 2020

    Tooth Bleaching Pain, Dentin Desensitizing Agents Trial in Belém (GCO (Experimental copaiba oil resin gel))

    Not yet recruiting
    • Tooth Bleaching Pain
    • Dentin Desensitizing Agents
    • GCO (Experimental copaiba oil resin gel)
    • Belém, PA, Brazil
      Federal University of Para
    Sep 27, 2023

    Auditory Processing Disorder Trial (Remote Microphone Hearing Aids)

    Completed
    • Auditory Processing Disorder
    • Remote Microphone Hearing Aids
    • (no location specified)
    Apr 27, 2020

    Using Virtual Reality in a Pain Management Group

    Unknown status
    • Chronic Pain
    • Immersive Virtual Reality
    • Barnsley, South Yorkshire, United Kingdom
      Inhealth Pain Management
    Feb 6, 2020

    Binge Eating Disorder, Obesity, Overweight Trial (Cognitive behavioral therapy plus general nutrition counseling (CBT+GN),

    Completed
    • Binge Eating Disorder
    • +2 more
    • Cognitive behavioral therapy plus general nutrition counseling (CBT+GN)
    • Cognitive behavioral therapy plus low energy density diet counseling (CBT+LED)
    • (no location specified)
    Mar 31, 2020

    Hearing Loss, Sensorineural Trial in Palos Hills, Nashville (Hearing aids)

    Completed
    • Hearing Loss, Sensorineural
    • Hearing aids
    • Palos Hills, Illinois
    • +1 more
    Apr 18, 2022